Cetera Investment Advisers’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	1,129,074 +29,324	+3%	+$44.5K	﹤0.01%	2502
2025 Q4	$2.19M	Buy	1,099,750 +298,500	+37%	+$459K	﹤0.01%	2132
2025 Q3	$1.31M	Buy	801,250 +184,078	+30%	+$360K	﹤0.01%	2539
2025 Q2	$1.41M	Buy	617,172 +92,300	+18%	+$153K	﹤0.01%	2105
2025 Q1	$814K	Buy	524,872 +168,650	+47%	+$342K	﹤0.01%	2434
2024 Q4	$837K	Buy	356,222 +224,222	+170%	+$758K	﹤0.01%	2285
2024 Q3	$479K	Sell	132,000 -2,500	-2%	-$9.97K	﹤0.01%	2683
2024 Q2	$468K	Buy	134,500 +2,719	+2%	+$11.7K	﹤0.01%	2646
2024 Q1	$841K	Buy	131,781 +281	+0.2%	+$1.75K	﹤0.01%	2212
2023 Q4	$847K	Sell	131,500 -2,500	-2%	-$9.54K	0.01%	1198
2023 Q3	$312K	Sell	134,000 -1,200	-0.9%	-$3.42K	﹤0.01%	1699
2023 Q2	$322K	Sell	135,200 -6,400	-5%	-$15.2K	﹤0.01%	1695
2023 Q1	$261K	Buy	141,600 +4,000	+3%	+$7.82K	﹤0.01%	1787
2022 Q4	$261K	Buy	137,600 +2,200	+2%	+$5.56K	﹤0.01%	1743
2022 Q3	$290K	Buy	135,400 +8,400	+7%	+$24.9K	0.01%	1285
2022 Q2	$359K	Buy	127,000 +2,700	+2%	+$8.22K	0.01%	1297
2022 Q1	$518K	Buy	124,300 +9,550	+8%	+$40.2K	0.01%	1127
2021 Q4	$596K	Buy	114,750 +9,650	+9%	+$57.9K	0.01%	1081
2021 Q3	$688K	Buy	+105,100	New	+$664K	0.01%	944